Turn Therapeutics Inc.
TTRX
$4.85
-$0.39-7.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -101.46% | -101.46% | -18.54% | -18.54% | 46.56% |
| Total Depreciation and Amortization | 8.70% | 8.70% | 46.99% | 46.99% | -16.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 479.88% | 479.88% | 518.31% | 518.31% | -90.93% |
| Change in Net Operating Assets | 171.49% | 171.49% | -187.72% | -187.72% | 90.53% |
| Cash from Operations | -43.89% | -43.89% | -10.31% | -10.31% | 14.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.02% | 34.02% | -66.23% | -66.23% | -259.70% |
| Cash from Investing | 34.02% | 34.02% | -66.23% | -66.23% | -259.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 925.81% | 925.81% | -- | -- | -38.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 925.81% | 925.81% | -- | -- | -38.64% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 882.91% | 882.91% | 98.37% | 98.37% | -85.23% |